Additionally, Hill et al. conducted a meta-analysis to identify the change in the mutational status from baseline samples to samples of disease progression, and found that CHD2 was one of the present mutations of interest in mantle-cell lymphoma (MCL) [69]. Here, CHD2 is linked to mantle cell lymphoma.